BioAdvice is a preclinical GLP and GMP authorized contract research organization (CRO) owned by Minerva Imaging. Both companies have assisted biotech and the pharmaceutical industry with in vivo studies and R&D counseling. In vivo studies covers in vivo studies in rodents and non-rodents addressing objectives mainly within PK/PD, local tolerance/toxicity and medical devices. With Minerva Imaging the capabilities include specialized studies within oncology, cardiovascular disease and inflammation. Our imaging capabilities include but are not limited to SPECT/CT, PET/CT and MRI. We assist in making qualified pharmacological research and development possible for companies which do not have the necessary in-house resources and/or know-how. • Intensive attention and personalised service. • High quality. • High flexibility and rapid reporting. GLP-authorisation by the Danish Medicines Agency to perform preclinical pharmacological and toxicological studies. GMP-authorisation by the Danish Medicine Agency to perform biological quality control tests on human and veterinary medical products. Contact: www.BioAdvice.dk General mail: info@minervaimaging.com Administration & Production Lyshoejvej 21 DK-3650 Oelstykke TEL +45 38 25 20 15
Looking for a particular BioAdvice A/S employee's phone or email?
The BioAdvice A/S annual revenue was $3 million in 2026.
Claude Bensoussan is the Founder and Consultant of BioAdvice A/S.
2 people are employed at BioAdvice A/S.
The NAICS codes for BioAdvice A/S are [54171, 54, 5417, 541, 541714].
The SIC codes for BioAdvice A/S are [87, 873].